Accuracy of dry vaginal self-sampling for detecting high-risk human papillomavirus infection in cervical cancer screening: A cross-sectional study

Gynecologic Oncology

Volumn 134, Issue 2, 2014, Pages 302-308

  Haguenoer, K ^a,b   Giraudeau, B ^a,c   Gaudy Graffin, C ^a,b,c   De Pinieux, I ^d   Dubois, F ^b,d   Trignol Viguier, N ^b   Viguier, J ^b   Marret, H ^b,c   Goudeau, A ^a,b,c  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL OF TOURS   (France)

^c UNIVERSITÉ DE TOURS   (France)

^d Institut Inter Régional Pour la Santé IRSA   (France)

Author keywords

Cervical cancer; Dry swab; Human papillomavirus; Mass screening; Self sampling

Indexed keywords

CERVICAL CANCER; DRY SWAB; HUMAN PAPILLOMAVIRUS; MASS SCREENING; SELF SAMPLING;

ADULT; CROSS-SECTIONAL STUDIES; DIAGNOSTIC SELF EVALUATION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINA; YOUNG ADULT;

EID: 84905580594     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.05.026     Document Type: Article

References (33)

1. J. Ferlay, I. Soerjomataram, M. Ervik, R. Dikshit, Eser, and C. Mathers et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 2013 International Agency for Research on Cancer Lyon, France
2. E. Lǎǎrǎ, N.E. Day, and M. Hakama Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes Lancet 1 1987 1247 1249
3. M. Arbyn, A.O. Raifu, E. Weiderpass, F. Bray, and A. Anttila Trends of cervical cancer mortality in the member states of the European Union Eur J Cancer 45 2009 2640 2648
4. E. Gakidou, S. Nordhagen, and Z. Obermeyer Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities PLoS Med 5 2008 e132
5. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, and K.V. Shah et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19
6. N. Muñoz, F.X. Bosch, S. de Sanjosé, R. Herrero, X. Castellsagué, and K.V. Shah et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer N Engl J Med 348 2003 518 527
7. S. De Sanjose, W.G. Quint, L. Alemany, D.T. Geraets, J.E. Klaustermeier, and B. Lloveras et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study Lancet Oncol 11 2010 1048 1056
8. J. Cuzick, M. Arbyn, R. Sankaranarayanan, V. Tsu, G. Ronco, and M.-H. Mayrand et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries Vaccine 26 Suppl. 10 2008 K29 K41
9. S.L. Kulasingam, J.P. Hughes, N.B. Kiviat, C. Mao, N.S. Weiss, and J.M. Kuypers et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral JAMA 288 2002 1749 1757
10. P. Naucler, W. Ryd, S. Tornberg, A. Strand, G. Wadell, and K. Elfgren et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer N Engl J Med 357 2007 1589 1597
11. M.H. Mayrand, E. Duarte-Franco, I. Rodrigues, S.D. Walter, J. Hanley, and A. Ferenczy et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer N Engl J Med 357 2007 1579 1588
12. I.M. De Kok, J. van Rosmalen, J. Dillner, M. Arbyn, P. Sasieni, and T. Iftner et al. Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model BMJ 344 2012 e670
13. D.C. Rijkaart, J. Berkhof, L. Rozendaal, F.J. van Kemenade, N.W.J. Bulkmans, and D.A.M. Heideman et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial Lancet Oncol 13 2012 78 88
14. T.C. Wright, L. Denny, L. Kuhn, A. Pollack, and A. Lorincz HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer JAMA 283 2000 81 86
15. A.G. Bais, F.J. van Kemenade, J. Berkhof, R.H.M. Verheijen, P.J.F. Snijders, and F. Voorhorst et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs Int J Cancer 120 2007 1505 1510
16. M. Gök, D.A.M. Heideman, F.J. van Kemenade, J. Berkhof, L. Rozendaal, and J.W.M. Spruyt et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study BMJ 340 2010 c1040
17. D.E. Stewart, A. Gagliardi, M. Johnston, R. Howlett, P. Barata, and N. Lewis et al. Self-collected samples for testing of oncogenic human papillomavirus: a systematic review J Obstet Gynaecol Can 29 2007 817 828
18. C.E. Schmeink, R.L.M. Bekkers, L.F.A.G. Massuger, and W.J.G. Melchers The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening Rev Med Virol 21 2011 139 153
19. P.M. Bossuyt, J.B. Reitsma, D.E. Bruns, C.A. Gatsonis, P.P. Glasziou, and L.M. Irwig et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative BMJ 326 2003 41 44
20. D. Solomon, D. Davey, R. Kurman, A. Moriarty, D. O'Connor, and M. Prey et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology JAMA 287 2002 2114 2119
21. V. Fontaine, C. Mascaux, C. Weyn, A. Bernis, N. Celio, and P. Lefèvre et al. Evaluation of combined general primer-mediated PCR sequencing and type-specific PCR strategies for determination of human papillomavirus genotypes in cervical cell specimens J Clin Microbiol 45 2007 928 934
22. M. Safaeian, R. Herrero, A. Hildesheim, W. Quint, E. Freer, and L.-J. Van Doorn et al. Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica J Clin Microbiol 45 2007 1447 1454
23. E.F. Dunne, E.R. Unger, M. Sternberg, G. McQuillan, D.C. Swan, and S.S. Patel et al. Prevalence of HPV infection among females in the United States JAMA 297 2007 813 819
24. J.R. Landis, and G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1977 159 174
25. P.J.F. Snijders, A.J.C. van den Brule, and C.J.L.M. Meijer The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity J Pathol 201 2003 1 6
26. H. Cerigo, F. Coutlée, E.L. Franco, and P. Brassard Dry self-sampling versus provider-sampling of cervicovaginal specimens for human papillomavirus detection in the Inuit population of Nunavik, Quebec J Med Screen 19 2012 42 48
27. R. Van Baars, R.P. Bosgraaf, B.W.A. ter Harmsel, W.J.G. Melchers, W.G.V. Quint, and R.L.M. Bekkers Dry storage and transport of a cervicovaginal self-sample by use of the Evalyn Brush, providing reliable human papillomavirus detection combined with comfort for women J Clin Microbiol 50 2012 3937 3943
28. L. Darlin, C. Borgfeldt, O. Forslund, E. Hénic, J. Dillner, and P. Kannisto Vaginal self-sampling without preservative for human papillomavirus testing shows good sensitivity J Clin Virol 56 2013 52 56
29. I. Eperon, P. Vassilakos, I. Navarria, P.-A. Menoud, A. Gauthier, and J.-C. Pache et al. Randomized comparison of vaginal self-sampling by standard vs. dry swabs for human papillomavirus testing BMC Cancer 13 2013 353
30. C.H. Lenselink, R.P. de Bie, D. van Hamont, J.M.J.E. Bakkers, W.G.V. Quint, and L.F.A.G. Massuger et al. Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening J Clin Microbiol 47 2009 2564 2570
31. I. Gustavsson, K. Sanner, M. Lindell, A. Strand, M. Olovsson, and I. Wikström et al. Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge J Clin Virol 51 2011 255 258
32. Y. Guan, P.E. Gravitt, R. Howard, Y.J. Eby, S. Wang, and B. Li et al. Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens J Virol Methods 189 2013 167 171
33. D.T. Geraets, R. van Baars, I. Alonso, J. Ordi, A. Torné, and W.J.G. Melchers et al. Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge J Clin Virol 57 2013 125 129